| Genome-Wide Association Study Identifies ROBO2 as a Novel Susceptibility Gene for Anthracycline-Related Cardiomyopathy in Childhood Cancer Survivors X Wang, P Singh, L Zhou, N Sharafeldin, W Landier, L Hageman, ... Journal of Clinical Oncology 41 (9), 1758-1769, 2023 | 9 | 2023 |
| Identification of novel hypermethylated or hypomethylated CpG sites and genes associated with anthracycline-induced cardiomyopathy P Singh, L Zhou, DA Shah, RB Cejas, DK Crossman, M Jouni, T Magdy, ... Scientific reports 13 (1), 12683, 2023 | 6 | 2023 |
| Altered Peripheral Blood Gene Expression in Childhood Cancer Survivors With Anthracycline‐Induced Cardiomyopathy–A COG‐ALTE03N1 Report P Singh, DA Shah, M Jouni, RB Cejas, DK Crossman, T Magdy, S Qiu, ... Journal of the American Heart Association 12 (19), e029954, 2023 | 3 | 2023 |
| Haptoglobin gene expression and anthracycline-related cardiomyopathy in childhood cancer survivors: a COG-ALTE03N1 report P Singh, DK Crossman, L Zhou, X Wang, N Sharafeldin, L Hageman, ... Cardio Oncology 5 (3), 392-401, 2023 | 3 | 2023 |
| Gene-level analysis of anthracycline-induced cardiomyopathy in cancer survivors: a report from COG-ALTE03N1, BMTSS, and CCSS N Sharafeldin, L Zhou, P Singh, DK Crossman, X Wang, L Hageman, ... Cardio Oncology 5 (6), 807-818, 2023 | 2 | 2023 |
| Polygenic risk of anthracycline-related cardiomyopathy in childhood cancer survivors: Report from children’s oncology group and childhood cancer survivor study. N Sharafeldin, X Wang, F Wang, P Singh, L Zhou, W Landier, L Hageman, ... Journal of Clinical Oncology 41 (16_suppl), 12090-12090, 2023 | | 2023 |
